Boston Partners’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
MG
FCM
Boston Partners's EXEL Position: Q1 2020 in Review
Boston Partners sold out of Exelixis (EXEL) in Q1 2020, closing a stake of 99,229 shares — an estimated $1.75M sold.
Boston Partners first reported a position in EXEL in Q4 2018 and held it in 5 quarters. The position peaked at $3.73M in Q1 2019. 337 funds tracked by Wall St. Rank hold EXEL as of Q1 2020.
- Boston Partners reported no remaining Exelixis position as of Q1 2020 after selling out during the quarter.
- Boston Partners sold 99,229 Exelixis shares in Q1 2020, an estimated $1.75M.
- Boston Partners first reported a position in Exelixis in Q4 2018 and held it in 5 quarters.
- Boston Partners's Exelixis position peaked at $3.73M in Q1 2019.
- 337 funds tracked by Wall St. Rank held Exelixis as of Q1 2020.
Based on Boston Partners's 13F filing for Q1 2020, filed 13 May 2020.